Skip to main content
TIANYU BIO-TECHNOLOGY CO.,LTD. logo

TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings

Ticker · 603717 ISIN · CNE1000030W1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,622 across all filing types
Latest filing 2023-01-20 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603717

About TIANYU BIO-TECHNOLOGY CO.,LTD.

https://www.tianyubiotech.com/

TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.

Recent filings

Filing Released Lang Actions
北京德恒律师事务所关于天域生态环境股份有限公司非公开发行股票的补充法律意见书
Audit Report / Information Classification · 95% confidence The document is a detailed legal opinion letter from a law firm regarding a company's non-public stock issuance. It extensively discusses the company's strategic investments, business operations, and financial details related to a specific investment in a subsidiary or related company. The content focuses on legal and financial due diligence, investment rationale, and compliance with securities laws. It is not a full annual or quarterly financial report, nor is it a simple announcement or certification. The document is a specialized legal opinion related to audit and regulatory compliance aspects of the company's financing activities, specifically concerning the non-public issuance of shares and related investment evaluations. Therefore, it fits best under the category of Audit Report / Information (AR), which includes standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests, excluding full annual reports. 9M 2022
2023-01-20 Chinese
天域生态第四届董事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the seventh meeting of the fourth board of directors of Tianyu Ecological Environment Co., Ltd. It details the board meeting date, attendance, voting results, and specific agenda items related to adjustments in a non-public stock issuance plan, including changes in fundraising amounts and share quantities. The document does not contain financial statements or detailed financial analysis but rather reports on board decisions and approvals. It is not an annual report, earnings release, or financial supplement. It is not a proxy solicitation or voting result declaration but a board meeting resolution announcement. The content fits best under Board/Management Information (MANG) as it concerns board meeting decisions and management-level approvals regarding capital raising plans.
2023-01-20 Chinese
天域生态关于控股股东所持股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge of shares held by the controlling shareholders of the company. It details the number of shares pledged, the proportion of total shares, the pledgee, and the impact on the company. There is no financial statement, earnings data, or management discussion. The document is a regulatory announcement about share pledging by major shareholders, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on share pledge details, not a full report or earnings release.
2023-01-19 Chinese
独立董事关于第四届董事会第六次会议相关议案的独立意见
Regulatory Filings
2023-01-17 Chinese
天域生态关于控股子公司增资扩股暨公司放弃优先增资权的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a capital increase in a controlling subsidiary and the company's waiver of preemptive rights to subscribe for the capital increase. It details the transaction structure, parties involved, financial data of the subsidiary, and the impact on the company. The document is a formal announcement of a financing event related to capital structure changes, specifically an equity investment and shareholding adjustment in a subsidiary. It does not contain comprehensive financial statements or detailed financial performance analysis typical of annual or interim reports. It is not a report publication announcement since it contains substantive transaction details and financial data. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2023-01-17 Chinese
天域生态关于控股股东部分股份质押延期的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the extension of a pledge on shares held by the controlling shareholder and actual controller of the company. It details the number of shares pledged, the pledge extension dates, and the impact on the company. There is no financial report, earnings data, or management discussion. The document is short (2164 characters) and serves as a disclosure of a shareholder's share pledge extension, which is a capital/financing update related to share pledges and financing arrangements. Therefore, it fits best under Capital/Financing Update (CAP).
2023-01-17 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.